Md. firm buys smallpox vaccine business in deal worth up to $125M

A Maryland life sciences company is acquiring a smallpox vaccine business from a French drug company in a deal worth up to $125 million. Emergent BioSolutions Inc., of Gaithersburg, has agreed to buy the Acam2000 smallpox vaccine business from Sanofi in a cash deal, with $97.5 million paid up front and as much as $27.5 million for …



Author: Baltimore Checkbook

Best in consumer news and deals in Baltimore, MD.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s